Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

1.5K
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
1.5K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

82
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
82
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

112
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
112
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

1.1K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.1K
Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

34.3K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
34.3K
Signs of Puberty01:27

Signs of Puberty

973
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
973

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experimental sepsis causes SERCA2 expression in white adipose tissue but not classical browning.

Scientific reports·2026
Same author

Mitochondrial L-2-hydroxyglutarate is a physiological signalling metabolite.

Nature·2026
Same author

Metformin inhibits mitochondrial complex I in intestinal epithelium to promote glycaemic control.

Nature metabolism·2026
Same author

Diet-induced phospholipid remodeling dictates ferroptosis sensitivity and tumorigenesis in the pancreas.

Cancer discovery·2026
Same author

Metformin inhibits mitochondrial complex I in intestinal epithelium to promote glycemic control.

bioRxiv : the preprint server for biology·2025
Same author

An orphan no more: SLC25A45 controls mitochondrial import of methylated amino acids.

Molecular cell·2025

Related Experiment Video

Updated: Nov 26, 2025

Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
06:08

Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Published on: May 19, 2023

2.6K

Testosterone metabolites differentially regulate obesogenesis and fat distribution.

Zachary L Sebo1, Matthew S Rodeheffer2

  • 1Yale University, Department of Molecular, Cellular and Developmental Biology, USA.

Molecular Metabolism
|December 11, 2020
PubMed
Summary
This summary is machine-generated.

Low testosterone (hypogonadism) worsens obesity and impairs glucose metabolism. Testosterone therapy, including its metabolites estradiol and dihydrotestosterone (DHT), helps manage fat mass and metabolic health.

Keywords:
AdipogenesisDiabetesFat distributionObesityTestosterone

More Related Videos

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

15.5K
Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.4K

Related Experiment Videos

Last Updated: Nov 26, 2025

Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
06:08

Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Published on: May 19, 2023

2.6K
Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

15.5K
Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.4K

Area of Science:

  • Endocrinology
  • Metabolic Health
  • Obesity Research

Background:

  • Low testosterone (hypogonadism) is linked to obesity and type II diabetes.
  • Testosterone replacement therapy can reverse these effects, but mechanisms are unclear.
  • Understanding testosterone's role in fat mass and metabolism is crucial.

Purpose of the Study:

  • To investigate how hypogonadism affects fat mass, distribution, and metabolic health.
  • To determine the specific roles of testosterone, dihydrotestosterone (DHT), and estradiol in regulating adipose tissue.

Main Methods:

  • Utilized mouse models of male hypogonadism.
  • Employed hormone replacement therapy, magnetic resonance imaging (MRI), and glucose tolerance tests.
  • Applied flow cytometry and immunohistochemical techniques for detailed analysis.

Main Results:

  • Castrated mice showed increased fat and reduced muscle mass, with impaired glucose metabolism.
  • Hypogonadism exacerbated obesity on a high-fat diet.
  • Testosterone, estradiol, and DHT differentially regulated visceral and subcutaneous fat mass, impacting adipocyte size and adipogenesis.

Conclusions:

  • Hypogonadism impairs glucose metabolism and promotes fat expansion via adipocyte hypertrophy and adipogenesis.
  • Testosterone, DHT, and estradiol play distinct roles in regulating fat mass and distribution.
  • Androgen signaling is vital in blocking diet-induced adipogenesis.